Search results
HaemaLogiX welcomes former Australian Federal Minister for Health Professor the Hon Greg Hunt to the...
WPRI Providence· 1 day agoHaemaLogiX Ltd, a clinical stage biotech developing novel immunotherapies for patients with blood cancers and B-cell diseases, is pleased to announce the ...
Research explains new method to engineer immune cells that could treat multiple cancer patients
Medical Xpress· 5 days agoTo tackle these limitations, UCLA researchers have developed a new, clinically guided method to engineer more powerful immune cells called invariant natural killer T cells, or iNKT cells, that ...
Report shows disparities in cancer outcomes based on race, location, sexuality
United Press International via Yahoo News· 6 days agoRace, location and sexuality all play a role in cancer disparities across the United States,...
FDA approves Amgen drug for tough-to-treat form of lung cancer
BioPharma Dive via Yahoo Finance· 4 days agoImdelltra, a bispecific antibody targeting a protein called DLL3, is cleared for use following...
What Is Immunophenotyping?
Healthline· 6 days agoImmunophenotyping helps doctors diagnose and classify specific blood cell cancers, like leukemia and lymphoma, as well as other diseases....
CTCL Global Care Collaborative Pioneers Consensus for Improving Diagnosis and Care in Cutaneous...
FOX 23 News Albany· 7 days agoKyowa Kirin, Inc. a wholly owned subsidiary of Kyowa Kirin Co. Ltd, today announced the publication of a patient-focused global consensus statement – 'Time to Act: A Global Patient-Focused Consensus ...
Legislative funding paves way for cancer center on the grounds of Middlesboro ARH
WKYT Lexington· 7 days agoRepresentatives from Appalachian Regional Healthcare recently gathered with local and state...
7 Biotech Stocks That Could Breathe New Life Into Your Portfolio
InvestorPlace· 17 hours agoFundamentally, one of the biggest advantages of biotech stocks to buy centers on the underlying...
New Clozapine Data Suggest FDA Should Ease Restrictions
Medscape· 6 days agoThe risk for severe neutropenia with clozapine is minimal, suggesting that burdensome FDA-required hematologic monitoring should be relaxed, researchers said.
Council Post: The Business Case For Expanding Diversity In Clinical Trials
Forbes· 5 days agoBy now, you’ve heard why expanding representation in clinical trial populations matters for health...